PCN248 COST-UTILITY ANALYSIS OF FIRST-LINE THERAPY FOR ADVANCED AND METASTATIC PANCREATIC CANCER IN JAPAN.
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.443
https://www.valueinhealthjournal.com/article/S1098-3015(19)32821-9/fulltext
Title :
PCN248 COST-UTILITY ANALYSIS OF FIRST-LINE THERAPY FOR ADVANCED AND METASTATIC PANCREATIC CANCER IN JAPAN.
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32821-9&doi=10.1016/j.jval.2019.09.443
First page :
Section Title :
Open access? :
No
Section Order :
10370